Advancing microbiome therapy with clarity and care.
We are a clinical-first therapeutics team focused on safe, scalable microbiome interventions for complex gastrointestinal and oncology needs.
Our mission
LND Therapeutics designs FMT-based solutions that prioritize safety, traceability, and measurable outcomes. We work closely with clinical teams to reduce barriers to adoption while improving patient support.
Guided by evidence
Programs are built around peer-reviewed protocols and ongoing real-world data collection.
Quality systems
Documented donor screening, manufacturing, and cold-chain logistics.
Clinical enablement
Training resources, onboarding, and clinical support for providers.
Ethical sourcing
Transparent consent, compensation, and long-term donor engagement.
Patient-centric
Clear education and follow-up protocols for every program.
A multidisciplinary team
Our clinicians, microbiologists, and product experts collaborate to advance patient-ready microbiome therapies.
Clinical Advisory Council
Gastroenterology, oncology, and infectious disease specialists guide protocol development and clinical safety.
Operations & Quality
Dedicated quality systems and logistics teams ensure repeatable outcomes.